Manufacturer record
Concept Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Concept Pharmaceuticals Ltd (Maharashtra) were declared Not of Standard Quality between December 2020 and January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: C21D93400 3, Metformin Hydrochloride Sustained Release Tablets I.P. 500mg (Conmet SR- 500) (exp May 2027). CDL Kolkata (CDSCO lab) found it not of standard quality: Dissolution. Listed in the January 2025 alert.
Records by type
11 records linked to Concept Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metformin Hydrochloride Sustained Release Tablets I.P. 500mg (Conmet SR- 500) | Batch C21D93400 3Mfg Jun 2024 · Exp May 2027 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2025 |
| Aluminium, Magnesium &Simethicone Oral Suspension I.P | Batch C21A133003Mfg Jun 2023 · Exp May 2026 | Description onlyDescription | State Lab KarnatakaState lab | Dec 2024 |
| Ofloxacin Dispersible Tablets IP 100 mg (Oflab 100 DT) | Batch C21O062001Mfg May 2022 · Exp Apr 2024 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Feb 2024 |
| Isoniazid Tablets IP 300 mg (Isocon -300) | Batch C21I263005Mfg Jul 2023 · Exp Jun 2027 | AssayAssay | CDTL MumbaiCDSCO lab | Oct 2023 |
| Albendazole Tablets I.P. 400 mg | Batch C21F943011Mfg Aug 2023 · Exp Jul 2026 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Oct 2023 |
| Rifampicin, Isoniazid, Pyrazinamide & Ethambutol Tablets I.P. (HRZE) | Batch C21R772013Mfg Jan 2022 · Exp Dec 2023 | Assay of RifampicinAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Ibuprofen and Paracetamol Dispersible Tablets (Ibucon Plus Kid) | Batch C211143 003Mfg Mar 2023 · Exp Feb 2026 | Diameter & Uniformity of DispersionUniformity of weight/content | CDTL MumbaiCDSCO lab | Aug 2023 |
| Losacon-H (Losartan Potassium & Hydrochlorothiazide Tablets I.P.) | Batch C21L262001Mfg Feb 2022 · Exp Jan 2024 | Assay of HydrochlorthiazideAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Telmicept 40 (Telmisartan Tablets I.P. 40 mg) | Batch C21T479003Mfg Sep 2019 · Exp Aug 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2021 |
| TELMISARTAN TABLETS I.P. 40 mg (TELMICEPT-40 TABLETS) | Batch C21T470002Mfg Jul 2020 · Exp Jun 2023 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2021 |
| Telmicept ? 40 (Telmisartan Tablets I.P. 40 mg) | Batch C21T479003Mfg Sep 2019 · Exp Aug 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.